Almirall, a global pharmaceutical company member of CataloniaBio & HealthTech, launches its fifth call AlmirallShare to establish collaborations in research and identify new treatments for skin health.
The call seeks partnering opportunities for new assets (chemical entities, biologics and other advanced therapies) in order to maximize their value as innovative therapies.
Scientists all over the world can submit their proposal until 31 October, 2020.
AlmirallShare, led by Maribel Crespo, is responsible for 50% of the private-public collaborations at Almirall. This open innovation platform has received more than 350 proposals since its launch in 2017.
El gen AtCDF3 promueve una mayor producción de az...
Un estudio con datos de los últimos 35 años, ind...
Un equipo de investigadores de la Universidad Juli...
En nuestro post hablamos sobre este interesante tipo de célula del si...
Han estudiado si la aterosclerosis asociada a HGPS puede evitarse medi...
